Comments
Loading...

Rubius Therapeutics Inc Com

RUBYOTC
Logo brought to you by Benzinga Data
15 minutes delayed

Rubius Therapeutics Inc Com (OTC:RUBY) Stock, Earnings Estimates, EPS, And Revenue

Rubius Therapeutics Inc Com reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 27
EPS
$-0.220
Quarterly Revenue
$0K
Annual Revenue

Analyze the earnings history of Rubius Therapeutics Inc Com using advanced sorting and filters.

Data brought to you by Benzinga APIs

Rubius Therapeutics Inc Com (RUBY) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Dec 20222023-02-27$-0.22$-0.3435.3 %
Sep 20222022-11-09$-0.36$-0.397.69 %
Jun 20222022-08-09$-0.49$-0.537.55 %
Mar 20222022-05-10$-0.58$-0.580.00 %

Rubius Therapeutics Inc Com (RUBY) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Rubius Therapeutics Inc Com (OTC:RUBY) reporting earnings?

A

Rubius Therapeutics Inc Com ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 27, 2023 for Q4.

Q

What were the latest earnings per share (EPS) for Rubius Therapeutics Inc Com (OTC:RUBY)?

A

Rubius Therapeutics Inc Com ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 27, 2023 for Q4 and the Actual EPS was $-0.22, which beat the estimate of $-0.34.

Q

What were Rubius Therapeutics Inc Com’s (OTC:RUBY) revenues?

A

Rubius Therapeutics Inc Com ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 27, 2023 for Q4 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.